Xinyi International Secures Over RMB 200 Million Series C Funding Led by CICC Zhide

Recently, Xinyi International Digital Medical Systems (Dalian) Co., Ltd. (hereinafter referred to as “Xinyi International”) announced that it had secured Series C financing led by CICC Zhide Investment Management Co., Ltd. VCBeat (WeChat Official Account: vcbeat) has learned that the amount raised in this round exceeded RMB 200 million.

It is understood that Xinyi International previously secured Series A financing from Shiming Investment, Series B financing led by Zhongyu Capital and Israel’s Infinity Group, and Series B+ financing led by GF Direct Investment and the Han Jing Family Fund. What unique advantages does Xinyi International possess that have enabled it to successfully raise multiple rounds of funding?

2016 was a year marked by the frequent introduction of favorable policies for national telemedicine and tiered diagnosis and treatment. At the “National Conference on Health and Wellness” held in August, President Xi Jinping positioned “tiered diagnosis and treatment” as the foremost among the five basic medical and health systems for the first time, calling for “breakthroughs.” Premier Li Keqiang also emphasized the need to vigorously advance the development of telemedicine service systems targeting grassroots, remote, and underdeveloped regions. Document No. 45 issued by the National Health and Family Planning Commission, titled “Notice on Promoting Pilot Programs for Tiered Diagnosis and Treatment,” explicitly listed 270 pilot cities. This unprecedented level of government support has brought significant opportunities to the development of telemedicine services.

In September, as one of the pilot provinces for national telemedicine policies, Guizhou Province decided to include telemedicine services in the coverage of the basic medical insurance fund. This significant announcement sent shockwaves through the healthcare sector, with media outlets vying to report on it using terms such as “milestone development” and “dawn for the industry.” As the contractor for Guizhou Province’s comprehensive telemedicine business management platform project, Winny International also garnered substantial media attention. Winny International is fully committed to creating an innovative service model for tiered diagnosis and treatment, building a multi-party win-win healthcare ecosystem, and continuously promoting the healthy operation of the entire hospital-centric healthcare value chain. Its products and service capabilities have been widely recognized and acclaimed by the market, while also attracting favor from the investment community.

Recently, CICC Zhide Investment Management Co., Ltd., a wholly-owned direct investment subsidiary of China International Capital Corporation (CICC), completed its lead investment in the Series C financing round of Xinyi International Digital Medical System (Dalian) Co., Ltd. (hereinafter referred to as “Xinyi International”). The co-investment in this round attracted interest from multiple investment institutions, with funds raised exceeding RMB 200 million to date. This round of financing is expected to officially close after the National Day holiday in October this year. Previously, Xinyi International had secured Series A financing led by Shiming Investment, Series B financing co-led by Zhongyu Capital and Israel’s Infinity Group, and Series B+ financing co-led by GF Direct Investment and the Hanjing Family Fund.

Established in June 2010, Xinyi International is a specialized service provider focused on tiered diagnosis and treatment systems and innovative healthcare solutions. With over six years of market presence, Xinyi International has secured multiple patents, built a distributor network comprising hundreds of partners, and extended its services across 31 provinces, municipalities, and autonomous regions in China. The company serves more than 3,000 hospital clients and has established the largest professional tiered diagnosis and treatment platform in the country. The senior management team at Xinyi International averages over 15 years of experience in the healthcare or IT industries, while more than 70% of its team members hold medical degrees or possess relevant clinical service experience.

Mr. Shan Junbao, General Manager of CICC Zhide, stated: “Xinyi’s rapid and accurate deployment in China’s tiered diagnosis and treatment sector, its open platform model, the founding team’s strong healthcare industry background, and its outstanding operational service capabilities are the key factors driving Xinyi International’s rapid growth, as well as the primary reasons for our swift final investment decision.”

In 2016, Heart Medical International had established and operated three national-level demonstration telemedicine comprehensive consultation platform projects in Henan, Qinghai, and Guizhou provinces; supported the development of more than 50 national-level telemedicine platforms; and extended its platform services to over 3,000 hospitals at the county level and above across China, reaching more than 180,000 primary care physicians. Cumulatively, hundreds of thousands of remote consultations and second-opinion diagnoses were conducted, benefiting a population of over 400 million people in grassroots areas below the county level. Meanwhile, Heart Medical International has engaged in in-depth telemedicine collaborations with leading specialized hospitals and top-tier physician groups both domestically and internationally, further deepening its expertise in specialized telemedicine sectors.

Xinyi’s multi-tiered medical collaboration platform has provided construction, operation, and services for over 60 medical consortium projects of various types and levels across China. Tailoring solutions to local conditions, it has developed customized implementation plans for tiered diagnosis and treatment in multiple regions nationwide, earning widespread acclaim within the industry. As a pioneer in China’s tiered diagnosis and treatment platforms, Xinyi International has built the country’s only triage platform that comprehensively integrates backend medical resources with frontend patient flow. It also established China’s first remote triage center, leveraging telemedicine to support the development of medical consortia. By establishing mechanisms for coordinated planning and collaborative division of labor among medical institutions at all levels, Xinyi is committed to enhancing the diagnostic and therapeutic capabilities and operational efficiency of primary care institutions, rationally diverting patient flow, optimizing the allocation of medical resources, and effectively advancing the implementation of tiered diagnosis and treatment.

In July of this year, XinYi International was successfully selected for the second batch of investment projects under the 2016 central budgetary plan for the National Development and Reform Commission’s “Internet Plus” Major Engineering Project. It became the only Internet Plus major engineering project in the medical field supported by the state during this round. By 2018, XinYi International is expected to help 6,000 hospitals establish multi-level medical collaboration platforms, assisting the government in building a tiered diagnosis and treatment system and fostering new service models for the application and development of big data in health and medical care.

As Xinyi International’s open-platform strategy of “Tiered Diagnosis and Treatment+” continues to deepen, Xinyi has embarked on comprehensive industrial chain collaborations with strategic partners such as Baidu Doctor, XYWY.com, Alibaba Cloud, AstraZeneca, and Taikang Online. These efforts are dedicated to building a multi-party, win-win healthcare ecosystem and steadily promoting the healthy operation of the entire medical value chain centered on hospitals, experts, and data.